Sign in
Use of sulfonylureas and other potassium channel regulators to treat secretory diarrhea
Patent   Open access

Use of sulfonylureas and other potassium channel regulators to treat secretory diarrhea

Michael J Welsh and David N Sheppard
United States Patent and Trademark Office
08/10/1993
pdf
Use of sulfonylureas and other potassium channel regulators to tr285.20 kBDownloadView
PDM V1.0,  Open Access

Abstract

Methods for the treatment of secretory diarrhea comprised of administering to a patient in need thereof, an effective amount of a CFTR chloride channel blocker or a potassium channel opener are disclosed. The CFTR chloride channel blocker is a sulfonylurea of the group consisting of tolbutamide, glibenclamide, and related analogs. The potassium channel opener is selected from the group consisting of diazoxide, lemakalim, and minoxidil sulfate.

Details

Metrics

20 File views/ downloads
19 Record Views